Matches in SemOpenAlex for { <https://semopenalex.org/work/W2031788180> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W2031788180 endingPage "437" @default.
- W2031788180 startingPage "433" @default.
- W2031788180 abstract "Several post-hoc studies have shown that lack of early improvement reduces the chance of later response or remission. This post-hoc analysis evaluates different cut-off points of non-improvement at 4 weeks of escitalopram treatment to predict 8-week non-response and non-remission.This study consisted of MDD patients with an absence of improvement (<30% reduction in baseline score of the HAMD-17) at Week 4 of escitalopram treatment (10mg/day) that continued escitalopram treatment (10-20mg/day) for a further 4-week period (n=251). Predictive, sensitivity and specificity values for the several definitions of non-improvement (≤ 25%, ≤ 20% and ≤ 15% reduction in the HAMD-17 baseline total score) at 4 weeks were calculated.Overall, 70.1% (176/251) of patients did not achieve response at Week 8 and 84.5% (212/251) did not achieve remission. The predictive value for non-response was high (71.4-74.3%) for all cut-off points of non-improvement tested. The respective values for non-remission were placed between 85.0% and 87.2%.This was a post-hoc subgroup analysis. The only drug assessed was escitalopram.Our data indicate that an absence of improvement, <30% reduction in the HAMD-17, after 4 weeks of escitalopram treatment should prompt clinicians to consider a change in treatment strategy. Similar findings were previously reported for other antidepressants." @default.
- W2031788180 created "2016-06-24" @default.
- W2031788180 creator A5001555041 @default.
- W2031788180 creator A5048043719 @default.
- W2031788180 creator A5063639716 @default.
- W2031788180 creator A5086084955 @default.
- W2031788180 creator A5091749477 @default.
- W2031788180 date "2013-04-01" @default.
- W2031788180 modified "2023-10-16" @default.
- W2031788180 title "Different levels of lack of improvement at 4 weeks of escitalopram treatment as predictors of poor 8-week outcome in MDD" @default.
- W2031788180 cites W198074757 @default.
- W2031788180 cites W1991991343 @default.
- W2031788180 cites W1997010275 @default.
- W2031788180 cites W2013815418 @default.
- W2031788180 cites W2018725567 @default.
- W2031788180 cites W2026259136 @default.
- W2031788180 cites W2027185861 @default.
- W2031788180 cites W2030671409 @default.
- W2031788180 cites W2063291862 @default.
- W2031788180 cites W2086142410 @default.
- W2031788180 cites W2090777784 @default.
- W2031788180 cites W2091516275 @default.
- W2031788180 cites W2132699864 @default.
- W2031788180 cites W2151423698 @default.
- W2031788180 cites W2168322731 @default.
- W2031788180 cites W2320532711 @default.
- W2031788180 doi "https://doi.org/10.1016/j.jad.2012.07.035" @default.
- W2031788180 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22921481" @default.
- W2031788180 hasPublicationYear "2013" @default.
- W2031788180 type Work @default.
- W2031788180 sameAs 2031788180 @default.
- W2031788180 citedByCount "3" @default.
- W2031788180 countsByYear W20317881802018 @default.
- W2031788180 countsByYear W20317881802021 @default.
- W2031788180 countsByYear W20317881802023 @default.
- W2031788180 crossrefType "journal-article" @default.
- W2031788180 hasAuthorship W2031788180A5001555041 @default.
- W2031788180 hasAuthorship W2031788180A5048043719 @default.
- W2031788180 hasAuthorship W2031788180A5063639716 @default.
- W2031788180 hasAuthorship W2031788180A5086084955 @default.
- W2031788180 hasAuthorship W2031788180A5091749477 @default.
- W2031788180 hasConcept C118552586 @default.
- W2031788180 hasConcept C126322002 @default.
- W2031788180 hasConcept C15744967 @default.
- W2031788180 hasConcept C2777198177 @default.
- W2031788180 hasConcept C2779144063 @default.
- W2031788180 hasConcept C2779177272 @default.
- W2031788180 hasConcept C2779583969 @default.
- W2031788180 hasConcept C2780051608 @default.
- W2031788180 hasConcept C2781161787 @default.
- W2031788180 hasConcept C3018023364 @default.
- W2031788180 hasConcept C3019719930 @default.
- W2031788180 hasConcept C67761136 @default.
- W2031788180 hasConcept C71924100 @default.
- W2031788180 hasConceptScore W2031788180C118552586 @default.
- W2031788180 hasConceptScore W2031788180C126322002 @default.
- W2031788180 hasConceptScore W2031788180C15744967 @default.
- W2031788180 hasConceptScore W2031788180C2777198177 @default.
- W2031788180 hasConceptScore W2031788180C2779144063 @default.
- W2031788180 hasConceptScore W2031788180C2779177272 @default.
- W2031788180 hasConceptScore W2031788180C2779583969 @default.
- W2031788180 hasConceptScore W2031788180C2780051608 @default.
- W2031788180 hasConceptScore W2031788180C2781161787 @default.
- W2031788180 hasConceptScore W2031788180C3018023364 @default.
- W2031788180 hasConceptScore W2031788180C3019719930 @default.
- W2031788180 hasConceptScore W2031788180C67761136 @default.
- W2031788180 hasConceptScore W2031788180C71924100 @default.
- W2031788180 hasIssue "3" @default.
- W2031788180 hasLocation W20317881801 @default.
- W2031788180 hasLocation W20317881802 @default.
- W2031788180 hasOpenAccess W2031788180 @default.
- W2031788180 hasPrimaryLocation W20317881801 @default.
- W2031788180 hasRelatedWork W1981852180 @default.
- W2031788180 hasRelatedWork W1983506558 @default.
- W2031788180 hasRelatedWork W2008582715 @default.
- W2031788180 hasRelatedWork W2093749524 @default.
- W2031788180 hasRelatedWork W2277786844 @default.
- W2031788180 hasRelatedWork W2569566349 @default.
- W2031788180 hasRelatedWork W4200587029 @default.
- W2031788180 hasRelatedWork W4212855638 @default.
- W2031788180 hasRelatedWork W4320032910 @default.
- W2031788180 hasRelatedWork W2082998234 @default.
- W2031788180 hasVolume "146" @default.
- W2031788180 isParatext "false" @default.
- W2031788180 isRetracted "false" @default.
- W2031788180 magId "2031788180" @default.
- W2031788180 workType "article" @default.